Global Amyloidosis Treatment Market by Type (Medication, Surgery), End-Users (Hospitals, Specialty Centers) - Forecast 2024-2030- Product Image

Sale

Global Amyloidosis Treatment Market by Type (Medication, Surgery), End-Users (Hospitals, Specialty Centers) - Forecast 2024-2030

Report
188 Pages
March 2024
Region: Global
360iResearch™
ID: 5888733

UP TO €846EUR$875USD£717GBP OFF until Dec 31^st 2024

The Amyloidosis Treatment Market size was estimated at USD 5.23 billion in 2023, USD 5.70 billion in 2024, and is expected to grow at a CAGR of 7.57% to reach USD 8.73 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Amyloidosis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Amyloidosis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Amyloidosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbvie, Inc., Acrotech Biopharma, Inc, Alexion Pharmaceuticals, Alnylam Pharmaceuticals Inc., Arcturus Therapeutics, Inc., Astellas Pharma, Inc., AstraZeneca PLC, Attralus, Inc., BridgeBio Pharma, Inc., Bristol-Myers Squibb Company, Corino Therapeutics, Inc., GlaxoSmithKline PLC, Ionis Pharmaceuticals, Inc., Johnson & Johnson Services Inc, Merck & Co., Inc., Neurimmune AG, Oncopeptides AB, Pfizer Inc., Proclara Biosciences Inc., Prothena Corporation PLC, Regeneron Pharmaceuticals Inc., SOM INNOVATION BIOTECH, SA,, Sorrento Therapeutics, Inc., Spectrum Pharmaceuticals, Inc., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Amyloidosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Medication
  - Chemotherapy
  - Targeted therapy
    - Anti-Angiogenesis Therapy
    - Monoclonal Antibodies
    - Proteasome Inhibitors
- Surgery
  - Bone Marrow Transplantation/Stem Cell Transplantation
  - Organ Transplantation
End-Users
- Hospitals
- Specialty Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Amyloidosis Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Amyloidosis Treatment Market?
What are the technology trends and regulatory frameworks in the Amyloidosis Treatment Market?
What is the market share of the leading vendors in the Amyloidosis Treatment Market?
Which modes and strategic moves are suitable for entering the Amyloidosis Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Amyloidosis Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant prevalence of amyloidosis among rising gigantic population
5.1.1.2. Growing awareness about early diagnosis and amyloidosis treatments
5.1.1.3. Robust research activities to develop novel amyloidosis drugs
5.1.2. Restraints
5.1.2.1. Issues related to high cost and reimbursement policies of amyloidosis treatments
5.1.3. Opportunities
5.1.3.1. Emergence of new treatment options for treating amyloidosis
5.1.3.2. Rising investments to develop modernized healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Complexities and risk associated with amyloidosis treatments
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Amyloidosis Treatment Market, by Type

6.1. Introduction
6.2. Medication
6.3.1. Chemotherapy
6.3.2. Targeted therapy
6.3.3.1. Anti-Angiogenesis Therapy
6.3.3.2. Monoclonal Antibodies
6.3.3.3. Proteasome Inhibitors
6.3. Surgery
6.4.1. Bone Marrow Transplantation/Stem Cell Transplantation
6.4.2. Organ Transplantation

7. Amyloidosis Treatment Market, by End-Users

7.1. Introduction
7.2. Hospitals
7.3. Specialty Centers

8. Americas Amyloidosis Treatment Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Amyloidosis Treatment Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Amyloidosis Treatment Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Abbvie, Inc.
12.1.2. Acrotech Biopharma, Inc
12.1.3. Alexion Pharmaceuticals
12.1.4. Alnylam Pharmaceuticals Inc.
12.1.5. Arcturus Therapeutics, Inc.
12.1.6. Astellas Pharma, Inc.
12.1.7. AstraZeneca PLC
12.1.8. Attralus, Inc.
12.1.9. BridgeBio Pharma, Inc.
12.1.10. Bristol-Myers Squibb Company
12.1.11. Corino Therapeutics, Inc.
12.1.12. GlaxoSmithKline PLC
12.1.13. Ionis Pharmaceuticals, Inc.
12.1.14. Johnson & Johnson Services Inc
12.1.15. Merck & Co., Inc.
12.1.16. Neurimmune AG
12.1.17. Oncopeptides AB
12.1.18. Pfizer Inc.
12.1.19. Proclara Biosciences Inc.
12.1.20. Prothena Corporation PLC
12.1.21. Regeneron Pharmaceuticals Inc.
12.1.22. SOM INNOVATION BIOTECH, SA,
12.1.23. Sorrento Therapeutics, Inc.
12.1.24. Spectrum Pharmaceuticals, Inc.
12.1.25. Takeda Pharmaceutical Company Limited
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. AMYLOIDOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. AMYLOIDOSIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. AMYLOIDOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. AMYLOIDOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. AMYLOIDOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AMYLOIDOSIS TREATMENT MARKET DYNAMICS
FIGURE 7. AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 10. AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMYLOIDOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. AMYLOIDOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. AMYLOIDOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. AMYLOIDOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AMYLOIDOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 8. AMYLOIDOSIS TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 11. AMYLOIDOSIS TREATMENT MARKET SIZE, BY ANTI-ANGIOGENESIS THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMYLOIDOSIS TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMYLOIDOSIS TREATMENT MARKET SIZE, BY PROTEASOME INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 16. AMYLOIDOSIS TREATMENT MARKET SIZE, BY BONE MARROW TRANSPLANTATION/STEM CELL TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMYLOIDOSIS TREATMENT MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 19. AMYLOIDOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMYLOIDOSIS TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 37. CANADA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 40. CANADA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 41. CANADA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 42. MEXICO AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 45. MEXICO AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 46. MEXICO AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 64. CHINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. CHINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 67. CHINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 68. CHINA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 69. INDIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 71. INDIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 72. INDIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 73. INDIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. JAPAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. JAPAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 81. JAPAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 82. JAPAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 83. JAPAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 104. TAIWAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. TAIWAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. THAILAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. THAILAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 111. THAILAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 112. THAILAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 113. THAILAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. VIETNAM AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. VIETNAM AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. DENMARK AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. DENMARK AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 127. DENMARK AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 130. EGYPT AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. EGYPT AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 132. EGYPT AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 133. EGYPT AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 134. EGYPT AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 135. FINLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. FINLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 137. FINLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 138. FINLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 139. FINLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 142. FRANCE AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 143. FRANCE AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 144. FRANCE AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. GERMANY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 148. GERMANY AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 155. ITALY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 158. ITALY AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 159. ITALY AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 170. NORWAY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NORWAY AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 172. NORWAY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 173. NORWAY AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 174. NORWAY AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 175. POLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. POLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 177. POLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 178. POLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 179. POLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 180. QATAR AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. QATAR AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 182. QATAR AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 183. QATAR AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 184. QATAR AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 200. SPAIN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SPAIN AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 203. SPAIN AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 204. SPAIN AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 210. SWITZERLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWITZERLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 215. TURKEY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. TURKEY AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 217. TURKEY AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 218. TURKEY AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 219. TURKEY AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM AMYLOIDOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM AMYLOIDOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM AMYLOIDOSIS TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM AMYLOIDOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM AMYLOIDOSIS TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 230. AMYLOIDOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 231. AMYLOIDOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 232. AMYLOIDOSIS TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

Abbvie, Inc.
Acrotech Biopharma, Inc
Alexion Pharmaceuticals
Alnylam Pharmaceuticals Inc.
Arcturus Therapeutics, Inc.
Astellas Pharma, Inc.
AstraZeneca PLC
Attralus, Inc.
BridgeBio Pharma, Inc.
Bristol-Myers Squibb Company
Corino Therapeutics, Inc.
GlaxoSmithKline PLC
Ionis Pharmaceuticals, Inc.
Johnson & Johnson Services Inc
Merck & Co., Inc.
Neurimmune AG
Oncopeptides AB
Pfizer Inc.
Proclara Biosciences Inc.
Prothena Corporation PLC
Regeneron Pharmaceuticals Inc.
SOM INNOVATION BIOTECH, SA,
Sorrento Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.7 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.73 Billion
Compound Annual Growth Rate	7.5%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,763GBP €3625EUR$3,749USD£3,070GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,500GBP €4593EUR$4,749USD£3,889GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,238GBP €5560EUR$5,749USD£4,708GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£4,975GBP €6527EUR$6,749USD£5,527GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,449GBP €8461EUR$8,749USD£7,165GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Amyloidosis Treatment - Global Strategic Business Report

Transthyretin Amyloidosis Treatment Global Market Report 2024

Transthyretin Amyloidosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Global Amyloidosis Treatment Market (2023-2028) Competitive Analysis, Impact of COVID-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

AL Amyloidosis - Pipeline Insight, 2024

About the Amyloidosis‎ Drug Market